Despite promising Phase 3 results, safety concerns, namely liver injury, have impacted Agios stock and could affect ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback